(EN) This invention provides novel benzothiophene compounds of formula (I), which are useful for the treatment of the various medical conditions associated with postmenopausal syndrome, as well as estrogen dependent diseases including cancer of the breast, uterus, and cervix. The present invention further relates to pharmaceutical formulations of compounds of formula (I).(FR) Cette invention se rapporte à de nouveaux composés de benzothiophènes représentés par la formule (I), qui s'avèrent utiles au traitement de divers troubles associés au syndrome post-ménopausique, et des maladies à dépendance oestrogénique, notamment le cancer du sein, de l'utérus et du col utérin. La présente invention se rapporte en outre à des compositions pharmaceutiques contenant les composés représentés par la formule (I).
Fluorescence enhancement of oligodeoxynucleotides modified with green fluorescent protein chromophore mimics upon triplex formation
5-positions of deoxyuridines, and subsequently, incorporated into the middle positions of oligodeoxynucleotides. These oligonucleotides were designed to form triplex DNA in order to encapsulate the GFP chromophores, mimicking GFP structures. Upon triplexformation, the embedded GFP chromophores exhibited fluorescence enhancement, suggesting the potential application of these fluorescent probes for the detection